INFORMATION:
Early blood-sugar levels in type 2 diabetes crucial for future prognosis
2021-07-08
(Press-News.org) People who get type 2 diabetes need to gain control of their blood-sugar levels -- fast. The years immediately after diagnosis are strikingly critical in terms of their future risk for heart attacks and death. This is shown by a joint study from the Universities of Gothenburg and Oxford.
In a collaboration between the University of Gothenburg in Sweden and the University of Oxford in the UK, the significance of blood sugar levels from the time type 2 diabetes is diagnosed for the risk of heart attacks and death has been studied. The project was led jointly by Professor Marcus Lind in Gothenburg and Professor Rury Holman in Oxford.
The research was based on a key trial in type 2 diabetes, the UK Prospective Diabetes Study (UKPDS). This new analysis examined the role of blood-sugar levels in the first years after type 2 diabetes was diagnosed for the prognosis of myocardial infarction and death 10-20 years later.
The results, presented in the scientific journal Diabetes Care, show that blood-sugar levels early in the course of the condition have a much greater impact on the future prognosis than had been thought previously. They show that targeting blood-sugar levels according to treatment guidelines (HbA1c 52 mmol/mol or lower) from the time of diagnosis was associated with an approximately 20 percent lower risk of death 10-15 years later, compared with targeting a higher blood-sugar level (HbA1c 63 mmol/mol). In addition, it showed that delaying the introduction of good blood-sugar levels until 10 years after diagnosis was associated with only a 3% lower risk of death.
"These latest results are evidence that proper early blood-sugar treatment in type 2 diabetes is crucial to optimise diabetes care. Previously we haven't performed this kind of analysis, or understood just how important early blood-sugar control is for the prognosis. They also mean that there is a need for a greater focus on detecting type 2 diabetes at the earliest opportunity to prevent people living with undetected high blood-sugar levels for several years," says Professor Marcus Lind.
Professor Rury Holman, from the Radcliffe Department of Medicine at the University of Oxford, said "These new results provide a mechanistic explanation for the glycaemic 'legacy effect', first identified by the UKPDS, whereby instituting good blood-sugar control in newly-diagnosed type 2 diabetes was shown to reduce the risks of diabetic complications and death for up to 30 years. The discovery of the 'legacy effect' has led treatment guidelines worldwide recommending the need to achieve good blood-glucose control as soon as possible".
ELSE PRESS RELEASES FROM THIS DATE:
Research encourages re-evaluation of special nerve treatment for chronic pain
2021-07-08
LONDON, ON - Hospital researchers from Lawson Health Research Institute have published a recent study that assessed the use of a specialized treatment for chronic pain and its impact on health care use and opioid prescribing.
Paravertebral blocks (PVBs) belong to a broader group of procedures called "nerve blocks." A recent Toronto Star report noted that OHIP has been billed $420 million for nerve block procedures since 2011. PVBs involve injecting medication around the nerves where they exit the bones of the spine, at different locations depending on the patient and the chronic pain they are experiencing. ...
Study identifies genetic risks for suicide death in individuals with bipolar disorder
2021-07-08
A new study shows that individuals with bipolar disorder who are exposed to significant trauma may be at greater risk for suicide death, suggesting that clinical diagnosis of or genetic predisposition to trauma-related conditions could be important factors to consider in suicide prevention.
Suicide is the 10th leading cause of death in the United States, accounting for over 40,000 deaths each year, and suicide death rates are 10 to 30 times higher for people with bipolar disorder than for the general population.
The research, spearheaded by Eric Monson, MD, PhD, and Hilary Coon, PhD, from the University of Utah, in collaboration with Virginia Willour, PhD, from the University of Iowa, set out to identify unique risk factors for suicide attempt and death ...
Brain mapping method illuminates targets for treating neuropsychiatric symptoms
2021-07-08
Researchers have made significant advancements in correlating aberrations in specific brain circuits with neuropsychiatric conditions like depression. However, it remains difficult to prove that damage to these circuits causes the symptoms themselves and that targeting them with therapeutics could help patients. By integrating brain lesion datasets with data on how two treatments -- deep brain stimulation (DBS) and transcranial magnetic stimulation (TMS) -- influence neuropsychiatric disorders, researchers from Brigham and Women's Hospital and collaborators developed a new brain mapping approach that may help clarify the cause of a variety of neuropsychiatric conditions and identify promising stimulation sites to target therapeutically. Findings are published ...
Engineering seeds to resist drought
2021-07-08
As the world continues to warm, many arid regions that already have marginal conditions for agriculture will be increasingly under stress, potentially leading to severe food shortages. Now, researchers at MIT have come up with a promising process for protecting seeds from the stress of water shortage during their crucial germination phase, and even providing the plants with extra nutrition at the same time.
The process, undergoing continued tests in collaboration with researchers in Morocco, is simple and inexpensive, and could be widely deployed in arid regions, the researchers say. ...
Dealing with global carbon debt
2021-07-08
As atmospheric concentrations of CO2 continue to rise, we are putting future generations at risk of having to deal with a massive carbon debt. IIASA researchers and international colleagues are calling for immediate action to establish responsibility for carbon debt by implementing carbon removal obligations, for example, during the upcoming revision of the EU Emissions Trading Scheme.
Over the last several decades, governments have collectively pledged to slow global warming through accords such as the Kyoto Protocol and the Paris Agreement. Despite the ratification of these agreements by a large number of countries, the atmospheric concentration of CO2 continues to rise. At the rate we are going, we are well on our way to using up the remaining quantity of CO2 emissions to limit temperature ...
Arab participation in global genomic study could lead to new therapies for COVID patients
2021-07-08
Doha, Qatar, July 8, 2021: In March 2020, thousands of scientists around the world united to answer a pressing and complex question: which genetic factors influence the wide variation in COVID-19 severity? Why are some patients severely affected while others escape with mild or no symptoms at all?
A comprehensive summary of their findings to date, published in Nature - the world's leading multidisciplinary science journal - revealed 13 loci, or locations in the human genome, that are strongly associated with infection or severe COVID-19. The researchers also identified causal factors such ...
Large genomic analysis highlights COVID-19 risk factors
2021-07-08
In March of 2020, thousands of scientists around the world united to answer a pressing and complex question: what genetic factors influence why some COVID-19 patients develop severe, life-threatening disease requiring hospitalization, while others escape with mild symptoms or none at all?
A comprehensive summary of their findings to date, published in Nature, reveals 13 loci, or locations in the human genome, that are strongly associated with infection or severe COVID-19. The researchers also identified causal factors such as smoking and high body mass index. These results come from one of the largest ...
Pfizer-BioNTech vaccine in patients undergoing cancer treatment
2021-07-08
What The Study Did: The SARS-CoV-2 BNT162b2 (Pfizer-BioNTech) vaccine appeared to be safe and achieve satisfactory serologic status in patients with cancer. While there was a lag in antibody production compared with the rate in the noncancer control group, seroconversion occurred in most patients after the second dose.
Authors: Irit Ben-Aharon, M.D., Ph.D., of the Rambam Health Care Campus in Haifa, Israel, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamaoncol.2021.2675)
Editor's Note: The article includes conflict of interest and funding/support disclosures. Please ...
'Tumor avatars' predict patients' response to immunotherapy
2021-07-08
Tumor fragments in the lab are able to predict whether the corresponding real-life patients will benefit from immunotherapy. "We've solved a major problem many scientists had been facing: preserving a tumors original composition and structure outside of the patient in the lab", says cancer researcher Daniela Thommen from the Netherlands Cancer Institute. On 8 July, the results of her study are published in Nature Medicine.
While some cancer patients experience incredible results from immunotherapy, many others do not benefit from this treatment, which puts patients' ...
COVID-19 infections among health care workers before, after vaccination
2021-07-08
What The Study Did: A decline in COVID-19 cases after the vaccination of health care workers in a region of California that experienced high rates of COVID-19 disease over the winter is reported in this single-center study.
Authors: Shruti K. Gohil, M.D., M.P.H., of the University of California, Irvine School of Medicine, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2021.15980)
Editor's Note: Please see the article for additional information, including other ...